INTECH Investment Management’s Immunome IMNM Stock Holding History

INTECH Investment Management’s Portfolio IMNM Stock Details IMNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$645K	Sell	30,460 -578	-2%	-$12.4K	0.01%	1228
2026 Q1	$679K	Buy	31,038 +4,023	+15%	+$89.5K	0.01%	1189
2025 Q4	$580K	Buy	27,015 +4,311	+19%	+$75.7K	0.01%	1429
2025 Q3	$266K	Sell	22,704 -17,861	-44%	-$178K	﹤0.01%	1901
2025 Q2	$377K	Buy	40,565 +6,141	+18%	+$50.3K	﹤0.01%	1761
2025 Q1	$232K	Buy	34,424 +15,463	+82%	+$148K	﹤0.01%	2014
2024 Q4	$201K	Buy	18,961 +3,974	+27%	+$48K	﹤0.01%	2028
2024 Q3	$219K	Buy	+14,987	New	+$213K	﹤0.01%	1680

Other funds holding IMNM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

INTECH Investment Management's IMNM Position: Q2 2026 in Review

INTECH Investment Management reduced its Immunome (IMNM) stake by 1.9% in Q2 2026, selling an estimated $12.4K and leaving 30,460 shares worth $645K. The position accounts for 0.01% of the portfolio, ranked #1228.

INTECH Investment Management first reported a position in IMNM in Q3 2024 and has held it in 8 quarters since. The position peaked at $679K in Q1 2026. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

INTECH Investment Management held 30,460 shares of Immunome worth $645K as of Q2 2026.
INTECH Investment Management sold 578 Immunome shares in Q2 2026, an estimated $12.4K.
Immunome made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1228 holding.
INTECH Investment Management first reported a position in Immunome in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Immunome position peaked at $679K in Q1 2026.
202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.